Intramuscular Olanzapine Clinical Application and Specialized Nursing Techniques

Intramuscular (IM) olanzapine has become an important therapeutic option in the management of acute agitation and long-term treatment of psychiatric disorders such as schizophrenia and bipolar disorder. Although oral olanzapine is commonly prescribed, IM formulations—including short-acting injections for acute behavioural disturbances and long-acting injectable (LAI) olanzapine pamoate for maintenance therapy—play a crucial role when rapid symptom control or improved treatment adherence is required. IM olanzapine provides rapid onset of action by bypassing first-pass metabolism and achieving peak plasma levels within a short period, making it effective in emergency psychiatric situations. The LAI formulation helps maintain stable therapeutic drug levels, thereby reducing relapse, rehospitalization, and medication non-adherence in patients with chronic schizophrenia. However, the safe administration of IM olanzapine requires careful clinical assessment and specialized nursing techniques. Comprehensive nursing responsibilities include pre-administration evaluation of mental status, vital signs, comorbidities, and medication history; correct injection technique using recommended sites and aseptic procedures; and continuous post-injection monitoring. Particular attention is required for the rare but serious complication known as Post-Injection Delirium/Sedation Syndrome (PDSS), which necessitates mandatory observation after administration. In addition, nurses play a key role in documentation, patient education, and early recognition of adverse reactions such as hypotension, sedation, and respiratory depression. Overall, effective nursing management combined with appropriate clinical use ensures that IM olanzapine remains a safe and effective intervention for managing acute agitation and maintaining long-term stability in psychiatric patients.